Prevention of incident fracture of Osteoporosis in Japan(Multi-center Randomized Trial with Risedronate and VitaminK2).

Trial Profile

Prevention of incident fracture of Osteoporosis in Japan(Multi-center Randomized Trial with Risedronate and VitaminK2).

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2011

At a glance

  • Drugs Risedronic acid (Primary) ; Vitamin K
  • Indications Fracture; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms JOINT-03
  • Most Recent Events

    • 30 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 07 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top